e-learning
resources
Vienna 2009
Monday, 14.09.2009
From bench to bedside: diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical evaluation of QuantiFERON TB-2G test for patients with active tuberculosis disease stratified by age groups
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
Source:
Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Session:
From bench to bedside: diagnosis of tuberculosis
Session type:
E-Communication Session
Number:
1690
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan). Clinical evaluation of QuantiFERON TB-2G test for patients with active tuberculosis disease stratified by age groups. Eur Respir J 2009; 34: Suppl. 53, 1690
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Clinical evaluation of QuantiFERON TB -2g test in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Clinical and demographic characteristics of the tuberculin skin test positive patients without active tuberculosis contact
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Eur Respir J 2007; 30: 945-950
Year: 2007
The diagnosis value of QuantiFERON-TB gold test at patients with active tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
The tuberculin skin test and QuantiFERON test comparison in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Comparison of the QuantiFERON-TB and tuberculin skin test for detection of latent tuberculosis infection in cancer patients in a developing country
Source: ERJ Open Res, 5 (4) 00258-2018; 10.1183/23120541.00258-2018
Year: 2019
Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice
Source: Eur Respir J 2009; 33: 812-815
Year: 2009
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB)
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Immunologic tests in diagnosis of tuberculosis infection in children of different age.
Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others
Year: 2019
Tuberculin skin test and IGRA test in the diagnosis and follow-up of bacteriologically confirmed pulmonary tuberculosis in HIV negative adults
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Comparison of T-Spot.TB and tuberculin skin test among silicotic patients
Source: Eur Respir J 2008; 31: 266-272
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept